What development phase is Centrine in?

Centrine is FDA-approved (marketed).

What is the generic name of Centrine?

dimevamide is the generic (nonproprietary) name of Centrine.

Last reviewed 2026-04-20 · How we verify

Centrine (dimevamide)

FDA-approved active Quality 6/100

At a glance

Generic name	dimevamide
Drug class	dimevamide
Therapeutic area	Pain
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Centrine CI brief — competitive landscape report
Centrine updates RSS · CI watch RSS
portfolio CI